Judith K. Sato - Concepedia

Concepedia

Author

Judith K. Sato

City Of Hope National Medical Center

Also Known As

J K Sato, J Sato, J. Sato, J.K. Sato, Judith K Sato, Judith K. Sato, Judith Sato

41

Publications

1.8K

Citations

17

H-Index

27

Concepts

All Affiliations

City Of Hope National Medical Center Children's National Children's Hospital of Los Angeles University of Southern California Children's Oncology Group

JK

About

Judith K. Sato is an author at City Of Hope National Medical Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	222
2	Health Sciences	2	2	91
3	Cellular Therapies	1	1	28
4	Hepatology	1	1	77
5	Pathology	1	1	77

Judith K. Sato

×

19

Publications

1.8K

Citations

17

H-Index

	Year	Citations
Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, Journal of Clinical Oncology	2005	711
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors H. Stacy Nicholson, Cynthia S. Kretschmar, Mark Krailo, Cancer	2007	193
Distress screening, rater agreement, and services in pediatric oncology Sunita K. Patel, Wendy Mullins, Anne Turk, Psycho-Oncology	2010	94
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group Cindy L. Schwartz, Leonard H. Wexler, Mark Krailo, Pediatric Blood & Cancer	2015	91
Undifferentiated (Embryonal) Sarcoma of the Liver A Tumor of Uncertain Histogenesis Showing Divergent Differentiation Chisa Aoyama, Yoichi Hachitanda, Judith K. Sato, The American Journal of Surgical Pathology Tumoral PathologyDevelopmental BiologyHepatologyLiver A TumorHepatobiliary Tumor	1991	77
Pleuropulmonary Blastoma in Childhood Yoichi Hachitanda, Chisa Aoyama, Judith K. Sato, The American Journal of Surgical Pathology	1993	65
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Susan M. Blaney, Michael N. Needle, Andy Gillespie, PubMed Neuro-oncologyRadiation TherapyRefractory NeuroblastomaRecurrent NeuroblastomaMedicine	1998	63
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors Ted Zwerdling, Mark Krailo, Philip Monteleone, Cancer	2006	61
Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report Mitchell S. Cairo, Violet Shen, Mark Krailo, The American journal of pediatric hematology/oncology	2001	56
Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumors. Joseph Chao, G. Thomas Budd, Peiguo Chu, PubMed	2010	55

Page 1